These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system. Dunn JD, Cannon E, Mitchell MP, Curtiss FR. J Manag Care Pharm; 2006 May; 12(4):294-302. PubMed ID: 16792435 [Abstract] [Full Text] [Related]
25. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication? Tungol A, Starner CI, Gunderson BW, Schafer JA, Qiu Y, Gleason PP. J Manag Care Pharm; 2012 May; 18(9):690-700. PubMed ID: 23206212 [Abstract] [Full Text] [Related]
27. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance. Klepser DG, Huether JR, Handke LJ, Williams CE. J Manag Care Pharm; 2007 May; 13(9):765-77. PubMed ID: 18062728 [Abstract] [Full Text] [Related]
29. Evaluating the economic consequences of early antidepressant treatment discontinuation: a comparison between controlled-release and immediate-release paroxetine. Sheehan DV, Eaddy M, Sarnes M, Vishalpura T, Regan T. J Clin Psychopharmacol; 2004 Oct; 24(5):544-8. PubMed ID: 15349013 [Abstract] [Full Text] [Related]
32. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP). Perera PN, Guy MC, Sweaney AM, Boesen KP. J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804 [Abstract] [Full Text] [Related]